PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2011

Kollidon VA64, a membrane-resealing agent, reduces histopathology and improves functional outcome after controlled cortical impact in mice.

Mouse / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 22086196 ↗2011Reported benefit

Kollidon VA64, a membrane-resealing agent, reduces histopathology and improves functional outcome after controlled cortical impact in mice.

MouseTBIControlled cortical impactMaleIntravenous (comparator agents also given intracerebroventricularly)1 mmol/L, 500 microlitres1 h after controlled cortical impact

Model: Controlled cortical impact traumatic brain injury

Kollidon VA64 resealed injured cell membranes in vivo and significantly reduced acute cellular degeneration, chronic tissue damage, oedema, blood-brain barrier damage and motor deficits, although it did not rescue pulse-labelled propidium iodide positive cells from eventual death.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.78. Machine-extracted fields require source verification.